Detalles de la búsqueda
1.
Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis.
BMC Gastroenterol
; 20(1): 210, 2020 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32631250
2.
A GLP-1:CCK fusion peptide harnesses the synergistic effects on metabolism of CCK-1 and GLP-1 receptor agonism in mice.
Appetite
; 127: 334-340, 2018 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29782892
3.
Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice.
Am J Physiol Gastrointest Liver Physiol
; 302(8): G762-72, 2012 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22268099
4.
Combinations of an acetyl CoA carboxylase inhibitor with hepatic lipid modulating agents do not augment antifibrotic efficacy in preclinical models of NASH and fibrosis.
Hepatol Commun
; 6(9): 2298-2309, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35735253
5.
Targeting lipid biosynthesis pathways for hepatitis B virus cure.
PLoS One
; 17(8): e0270273, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35925919
6.
Peptide-YY3-36/glucagon-like peptide-1 combination treatment of obese diabetic mice improves insulin sensitivity associated with recovered pancreatic ß-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitries.
Mol Metab
; 55: 101392, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34781035
7.
Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies.
Proc Natl Acad Sci U S A
; 105(20): 7257-62, 2008 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-18458326
8.
Behavioural and neurochemical mechanisms underpinning the feeding-suppressive effect of GLP-1/CCK combinatorial therapy.
Mol Metab
; 43: 101118, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33221554
9.
Lack of an association between clinical INSTI-related body weight gain and direct interference with MC4 receptor (MC4R), a key central regulator of body weight.
PLoS One
; 15(2): e0229617, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32109250
10.
Resolution of NASH and hepatic fibrosis by the GLP-1R/GcgR dual-agonist Cotadutide via modulating mitochondrial function and lipogenesis.
Nat Metab
; 2(5): 413-431, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32478287
11.
Calcitonin Receptor Neurons in the Mouse Nucleus Tractus Solitarius Control Energy Balance via the Non-aversive Suppression of Feeding.
Cell Metab
; 31(2): 301-312.e5, 2020 02 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31955990
12.
Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution.
J Vis Exp
; (146)2019 04 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31058888
13.
The PYY/Y2R-Deficient Mouse Responds Normally to High-Fat Diet and Gastric Bypass Surgery.
Nutrients
; 11(3)2019 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30857366
14.
Combined loss of GLP-1R and Y2R does not alter progression of high-fat diet-induced obesity or response to RYGB surgery in mice.
Mol Metab
; 25: 64-72, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31126840
15.
Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source.
World J Gastroenterol
; 25(33): 4904-4920, 2019 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31543682
16.
Counterintuitive effects of double-heterozygous null melanocortin-4 receptor and leptin genes on diet-induced obesity and insulin resistance in C57BL/6J mice.
Endocrinology
; 149(1): 174-84, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17932216
17.
Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms.
Endocrinology
; 149(11): 5679-87, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18669592
18.
Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction.
World J Gastroenterol
; 24(16): 1748-1765, 2018 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29713129
19.
Differential Effects of a Glucagon-Like Peptide 1 Receptor Agonist in Non-Alcoholic Fatty Liver Disease and in Response to Hepatectomy.
Sci Rep
; 8(1): 16461, 2018 11 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30405191
20.
Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatment.
Sci Rep
; 8(1): 17545, 2018 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30510163